Menu Close

Modelling the Microelimination of Chronic Hepatitis C in the Canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy Goals Despite the Impact of the COVID 19 Pandemic

Journal Cover

Olivier Schorr, Sarah Blach, Christine Thurnheer, Christian Ruis, Jean-Francois Dufour


Summary

Since 2014, the Swiss Hepatitis Strategy (SHS) has targeted the elimination of Hepatitis C Virus (HCV) in Switzerland. The epidemiology of HCV is diverse across Swiss cantons, therefore cantonal-level screening and treatment strategies should be developed. This study aimed to identify scenarios to achieve HCV elimination in the canton of Bern by 2030. A preexisting Markov disease burden model was populated with data for Bern, and used to forecast the current and future prevalence of HCV, annual liver-related deaths (LRDs), and incidence of hepatocellular carcinoma and decompensated cirrhosis until 2030. Scenarios were developed to assess the current standard of care and potential long-term impact of the COVID-19 crisis on the HCV infected population. Additionally, potential scenarios for achieving the WHO 2030 targets and the SHS 2025 and 2030 targets (reduction of new cases of HCV, HCV-related mortality and viremic HCV cases) were identified.

en_USEnglish